Silver integrated hybrids and nanocomposites for next-generation biomedicine: Beyond antimicrobial coatings toward smart sense–response–heal platforms

Silver has re-emerged as a key material in biomedicine, functioning not only as an antimicrobial coating but also as a programmable nanoscale mediator that links infection control, tissue regeneration, and responsive therapeutics. At nanometer scales, silver's plasmonic, catalytic, and electronic properties differ significantly from those in bulk form. Advances in nanocomposite engineering have transitioned the field from simple antibacterial fillers to multifaceted platforms capable of sensing, signaling, and adapting to complex biological environments. By integrating silver with polymers, carbon allotropes, ceramics, metals, and bioactive scaffolds, researchers have developed silver nanocomposite-based architectures that promote angiogenesis, immunomodulation, electroactive regeneration, and staged therapeutic release. Additionally, the application of machine learning and multi-omics approaches provides predictive insights into how synthesis parameters, protein coronas, and cell responses may influence efficacy and toxicity, thus expediting the development of safe, biocompatible designs of silver nanocomposites. Realizing clinical potential requires reproducible fabrication, scalable manufacturing, and validation of dose parameters, oxidative stress responses, and immune compatibility. Clinically, silver nanocomposites have made significant progress, ranging from FDA-approved wound dressings and implant coatings to investigation platforms for cancer therapy, neural interfaces, and regenerative scaffolds. The future development of advanced silver nanocomposites will not be measured solely by their antimicrobial potency, but by integrating multiple orthogonal functions, including controlled ion release, mechanical reinforcement, electronic conductivity, and biological programming, within architectures verified through quantitative molecular readouts. Situated at the intersection of materials science, bioengineering, and regulatory science, silver nanocomposites offer a flexible platform poised to transform infection management, regenerative medicine, and precision therapeutics.